User login
Key clinical point: Persistence of COVID-19-related symptoms for 1 year after the onset of illness is common, even in some individuals with initial mild disease.
Major finding: Overall, 40.7% of participants continued to report 1 or more COVID-19-related symptoms at 12 months after illness onset. 16.4%, 49.5%, and 52.5% of patients with mild, moderate, and severe/critical COVID-19 had 1 or more COVID-19-related symptoms at 12 months after illness onset
Study details: The data come from a Dutch prospective cohort study (RECoVERED) involving 342 patients with COVID-19.
Disclosures: This study was supported by the Netherlands Organisation for Health Research and Development (ZonMw) and the Public Health Service of Amsterdam. A Boyd received a grant from ANRS and participated in the Data Safety Monitoring Board or Advisory Board for ZonMw for another study. G de Bree served as a paid member of the scientific advisory board of ExeVir. The remaining authors declared no conflict of interests.
Source: Wynberg E et al. Clin Infect Dis. 2021 Sep 2. doi: 10.1093/cid/ciab759.
Key clinical point: Persistence of COVID-19-related symptoms for 1 year after the onset of illness is common, even in some individuals with initial mild disease.
Major finding: Overall, 40.7% of participants continued to report 1 or more COVID-19-related symptoms at 12 months after illness onset. 16.4%, 49.5%, and 52.5% of patients with mild, moderate, and severe/critical COVID-19 had 1 or more COVID-19-related symptoms at 12 months after illness onset
Study details: The data come from a Dutch prospective cohort study (RECoVERED) involving 342 patients with COVID-19.
Disclosures: This study was supported by the Netherlands Organisation for Health Research and Development (ZonMw) and the Public Health Service of Amsterdam. A Boyd received a grant from ANRS and participated in the Data Safety Monitoring Board or Advisory Board for ZonMw for another study. G de Bree served as a paid member of the scientific advisory board of ExeVir. The remaining authors declared no conflict of interests.
Source: Wynberg E et al. Clin Infect Dis. 2021 Sep 2. doi: 10.1093/cid/ciab759.
Key clinical point: Persistence of COVID-19-related symptoms for 1 year after the onset of illness is common, even in some individuals with initial mild disease.
Major finding: Overall, 40.7% of participants continued to report 1 or more COVID-19-related symptoms at 12 months after illness onset. 16.4%, 49.5%, and 52.5% of patients with mild, moderate, and severe/critical COVID-19 had 1 or more COVID-19-related symptoms at 12 months after illness onset
Study details: The data come from a Dutch prospective cohort study (RECoVERED) involving 342 patients with COVID-19.
Disclosures: This study was supported by the Netherlands Organisation for Health Research and Development (ZonMw) and the Public Health Service of Amsterdam. A Boyd received a grant from ANRS and participated in the Data Safety Monitoring Board or Advisory Board for ZonMw for another study. G de Bree served as a paid member of the scientific advisory board of ExeVir. The remaining authors declared no conflict of interests.
Source: Wynberg E et al. Clin Infect Dis. 2021 Sep 2. doi: 10.1093/cid/ciab759.